TG Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 11/12/2025 | 21.30 M | $769.48 M | -2.35% | 14.52% |
| VANGUARD GROUP INC | 11/07/2025 | 15.52 M | $560.71 M | -1.82% | 10.58% |
| STATE STREET CORP | 11/14/2025 | 8.10 M | $292.63 M | 6.33% | 5.52% |
| CLEARBRIDGE INVESTMENTS, LLC | 11/13/2025 | 4.64 M | $167.78 M | 52.15% | 3.17% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 3.84 M | $138.89 M | 71.34% | 2.62% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 3.44 M | $125.04 M | -1.33% | 2.35% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/18/2025 | 1.61 M | $58.15 M | -15.62% | 1.10% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 11/14/2025 | 1.55 M | $56.09 M | -0.94% | 1.06% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 1.52 M | $54.89 M | -3.22% | 1.04% |
| NORTHERN TRUST CORP | 11/14/2025 | 1.50 M | $54.25 M | -2.21% | 1.02% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 1.31 M | $47.33 M | -0.48% | 0.89% |
| MORGAN STANLEY | 11/14/2025 | 1.25 M | $45.08 M | -11.04% | 0.85% |
| JANE STREET GROUP, LLC | 11/14/2025 | 1.13 M | $40.78 M | 60.11% | 0.77% |
| INVESCO LTD. | 11/13/2025 | 1.09 M | $39.53 M | 12.83% | 0.75% |
| MAN GROUP PLC | 11/14/2025 | 1.01 M | $36.43 M | 621.54% | 0.69% |
| CITADEL ADVISORS LLC | 11/14/2025 | 992.70 K | $35.86 M | -4.96% | 0.68% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 958.47 K | $34.62 M | -38.07% | 0.65% |
| EVENTIDE ASSET MANAGEMENT, LLC | 11/14/2025 | 954.53 K | $34.48 M | 0.00% | 0.65% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 889.87 K | $32.15 M | 45.00% | 0.61% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 872.55 K | $31.52 M | -3.74% | 0.59% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 808.50 K | $29.21 M | 29.32% | 0.55% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 785.60 K | $28.38 M | 16.28% | 0.54% |
| PRINCIPAL FINANCIAL GROUP INC | 11/04/2025 | 784.17 K | $28.33 M | -1.57% | 0.53% |
| CITIGROUP INC | 11/10/2025 | 746.92 K | $26.98 M | 8.88% | 0.51% |
| FMR LLC | 11/13/2025 | 711.34 K | $25.70 M | -54.17% | 0.48% |
| NUVEEN, LLC | 11/12/2025 | 710.77 K | $25.68 M | 8.16% | 0.48% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 708.33 K | $25.59 M | -41.37% | 0.48% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 674.13 K | $24.35 M | -0.68% | 0.46% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 626.65 K | $22.64 M | 10.45% | 0.43% |
| UBS GROUP AG | 11/13/2025 | 618.23 K | $22.33 M | 16.33% | 0.42% |
| JUMP FINANCIAL, LLC | 11/13/2025 | 595.36 K | $21.51 M | 86.04% | 0.41% |
| OPALEYE MANAGEMENT INC. | 11/14/2025 | 535.00 K | $19.33 M | 0.00% | 0.36% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 11/06/2025 | 529.27 K | $19.12 M | 14.47% | 0.36% |
| PENN CAPITAL MANAGEMENT COMPANY, LLC | 11/24/2025 | 521.26 K | $18.88 M | 17.57% | 0.36% |
| BANK OF MONTREAL /CAN/ | 11/13/2025 | 512.62 K | $18.52 M | -2.40% | 0.35% |
| SQUAREPOINT OPS LLC | 11/14/2025 | 504.63 K | $18.23 M | 100.00% | 0.34% |
| BARCLAYS PLC | 11/12/2025 | 458.23 K | $16.55 M | -26.16% | 0.31% |
| ROYAL BANK OF CANADA | 11/14/2025 | 456.23 K | $16.48 M | -32.25% | 0.31% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 428.20 K | $15.47 M | 246.72% | 0.29% |
| 11/14/2025 | 409.60 K | $14.80 M | 100.00% | 0.28% | |
| VOYA INVESTMENT MANAGEMENT LLC | 10/09/2025 | 404.73 K | $14.62 M | -4.27% | 0.28% |
| RHUMBLINE ADVISERS | 11/06/2025 | 402.41 K | $14.54 M | -0.56% | 0.27% |
| JANE STREET GROUP, LLC | 11/14/2025 | 398.50 K | $14.40 M | 62.19% | 0.27% |
| AMERIPRISE FINANCIAL INC | 11/14/2025 | 372.92 K | $13.47 M | -5.84% | 0.25% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 365.83 K | $13.22 M | -49.01% | 0.25% |
| CITADEL ADVISORS LLC | 11/14/2025 | 364.80 K | $13.18 M | -8.43% | 0.25% |
| NEW YORK STATE COMMON RETIREMENT FUND | 11/03/2025 | 358.82 K | $12.96 M | 7.80% | 0.24% |
| LEGAL & GENERAL GROUP PLC | 11/13/2025 | 351.61 K | $12.70 M | -3.97% | 0.24% |
| BRIDGEWATER ASSOCIATES, LP | 11/13/2025 | 342.15 K | $12.36 M | 100.00% | 0.23% |
| CITADEL ADVISORS LLC | 11/14/2025 | 325.80 K | $11.77 M | -34.33% | 0.22% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
TG Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 466 institutional investors and hedge funds held shares of TG Therapeutics, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 21.3 M
VANGUARD GROUP INC: 15.52 M
STATE STREET CORP: 8.1 M
Clearbridge Investments, LLC: 4.64 M
Soleus Capital Management, L.P.: 3.84 M
GEODE CAPITAL MANAGEMENT, LLC: 3.44 M
67.47% of TG Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 119.06 M shares in the last 24 months. This purchase volume represents approximately $4.37 B in transactions.